CoMind Secures $60M Investment for Non-Invasive Brain Monitoring Technology
CoMind, a London-based healthtech startup, has reportedly secured $60 million in funding to advance its non-invasive brain monitoring technology. The company’s device uses low-powered infrared lasers to measure cerebral blood flow and pressure without skull penetration. Sources indicate this funding round brings CoMind’s total investment to over $102 million.
Major Funding for Brain Monitoring Innovation
London-based healthtech startup CoMind has reportedly secured $60 million in a recent funding round, according to financial reports. The investment was led by Plural, an early-stage venture firm with operations in London and Tallinn, with participation from several other prominent investors.